Reactivation of human herpesvirus type 6 in multiple organ failure syndrome

被引:43
作者
Desachy, A
Ranger-Rogez, S
François, B
Venot, C
Traccard, I
Gastinne, H
Denis, F
Vignon, P
机构
[1] Dupuytren Hosp, Intens Care Unit, Limoges, France
[2] Dupuytren Hosp, Virol Lab, Limoges, France
关键词
D O I
10.1086/318474
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human herpesvirus type 6 (HHV-6) and cytomegalovirus (CMV) are known to interact with the production of cytokines. In this study, we sought to determine the incidence of HHV-6 and CMV reactivation during multiple organ failure syndrome (MOFS) and to evaluate the potential effects of viral replication on both the morbidity and mortality associated with MOFS. Viral reactivation was assessed by use of specific polymerase chain reaction (PCR) analysis of the serum samples obtained from 48 consecutive patients with MOFS (the MOFS group) and from 48 sex- and age-matched patients with <2 organ failures (the control group). In addition, HHV-6 replication was assessed in 106 blood donors (the normal group). The incidence of HHV-6 replication was higher in the MOFS group than in the control and normal groups (26 [54%] of 48 vs. 7 [15%] of 48 and 5 [5%] of 106, respectively; P <.0001), with apparently no influence on morbidity and mortality rates. In contrast, reactivation of CMV was found in a single patient. Further studies are needed to evaluate the pathogenesis of HHV-6 replication in critically ill patients.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 24 条
[1]   FATAL FULMINANT-HEPATITIS IN AN INFANT WITH HUMAN HERPESVIRUS-6 INFECTION [J].
ASANO, Y ;
YOSHIKAWA, T ;
SUGA, S ;
YAZAKI, T ;
KONDO, K ;
YAMANISHI, K .
LANCET, 1990, 335 (8693) :862-863
[2]   MULTIPLE ORGAN FAILURE SYNDROME IN THE 1990S - SYSTEMIC INFLAMMATORY RESPONSE AND ORGAN DYSFUNCTION [J].
BEAL, AL ;
CERRA, FB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (03) :226-233
[3]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[5]  
BRIGGS M, 1988, LANCET, V1, P1058
[6]  
BROWN NA, 1988, LANCET, V2, P396
[7]   HUMAN HERPESVIRUS-6 DNA IN PERIPHERAL-BLOOD CELLS AND SALIVA FROM IMMUNOCOMPETENT INDIVIDUALS [J].
CONE, RW ;
HUANG, MLW ;
ASHLEY, R ;
COREY, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (05) :1262-1267
[8]   HUMAN HERPESVIRUS-6 IN LUNG-TISSUE FROM PATIENTS WITH PNEUMONITIS AFTER BONE-MARROW TRANSPLANTATION [J].
CONE, RW ;
HACKMAN, RC ;
HUANG, MLW ;
BOWDEN, RA ;
MEYERS, JD ;
METCALF, M ;
ZEH, J ;
ASHLEY, R ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :156-161
[9]   CYTOMEGALOVIRUS REACTIVATION AND TUMOR-NECROSIS-FACTOR [J].
DOCKE, WD ;
PROSCH, S ;
FIETZE, E ;
KIMEL, V ;
ZUCKERMANN, H ;
KLUG, C ;
SYRBE, U ;
KRUGER, DH ;
VONBAEHR, R ;
VOLK, HD .
LANCET, 1994, 343 (8892) :268-269
[10]   FATAL ENCEPHALITIS DUE TO VARIANT-B HUMAN HERPESVIRUS-6 INFECTION IN A BONE MARROW-TRANSPLANT RECIPIENT [J].
DROBYSKI, WR ;
KNOX, KK ;
MAJEWSKI, D ;
CARRIGAN, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (19) :1356-1360